References
- Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7–17. doi: 10.1002/art.1780200102
- Burgdorfer W, Barbour A, Hayes S, Benach J, Grunwaldt E, Davis J. Lyme disease-a tick-borne spirochetosis? Science 1982;216:1317–9. doi: 10.1126/science.7043737
- Ryberg B. Bannwarth's Syndrome (Lymphocytic Meningoradiculitis) in Sweden. Yale J Biol Med 1984;57:499–503.
- Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringnér Å, Elmrud H, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995;333:1319–24. doi: 10.1056/NEJM199511163332004
- Strle F, Stanek G. Clinical manifestations and diagnosis of Lyme disease. Curr Prob Dermatol. 2009;37:51–110. doi: 10.1159/000213070
- Li X, McHugh GA, Damle N, Sikand VK, Glickstein L, Steere AC. Borrelia burgdorferi in skin and joints of patients with erythema Migrans or Lyme. Arthritis Rheum 2011;63:2238–47. Burden and Viability of. doi: 10.1002/art.30384
- Steere AC, Glickstein L. Elucidation of Lyme arthritis. Nat Rev Immunol 2004;4:143–45. doi: 10.1038/nri1267
- Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 2006;54:3079–86. doi: 10.1002/art.22131
- Holmgren EA, Matteson L. Lyme myositis. Arthritis Rheum 2006;54:2697–700. doi: 10.1002/art.22007
- Koedel U, Fingerle V, Pfister H-W. Lyme neuroborreliosis—epidemiology, diagnosis and management. Nat Rev Neurol 2015;11:446–56. doi: 10.1038/nrneurol.2015.121
- Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic Anaplasmosis, and Babesiosis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2006;43:1089–134. doi: 10.1086/508667
- Mygland Å, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis’. Eur J Neurol 2010;17:8–16. doi: 10.1111/j.1468-1331.2009.02862.x
- British Infection Association. The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: a position statement by the British Infection Association. J Infect. 2011;62:329–38. doi: 10.1016/j.jinf.2011.03.006
- Ljøstad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg Å, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 2008;7:690–5. doi: 10.1016/S1474-4422(08)70119-4
- Bremell D, Dotevall L. Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension. Eur J Neurol 2014;21:1162–7. doi: 10.1111/ene.12420